Article
Immunotherapeutic Potential of Mutated NPM1 for the Treatment of AML
2024-06-20
Abstract excerpt
Acute myeloid leukemia (AML) is a malignant disease of the blood and bone marrow that is characterized by uncontrolled clonal proliferation of abnormal myeloid progenitor cells. Nucleophosmin 1 (NPM1) gene mutations are the most common genetic abnormality in AML, detectable in blast cells from about one third of adults with AML. AML NPM1mut is recognized as a separate entity in the World Health Organization (WHO)...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 96e3ef63-7d86-59d5-9765-d98ad06fbe06
- DOI
- 10.20944/preprints202406.1388.v1
